Known since Hippocrates and of continuing public health importance, influenza remains a
major cause of morbidity and mortality worldwide, and large segments of the human …

Influenza vaccine is considered the most effective way to prevent influenza. Nonetheless,
every year vaccine coverage is lower than recommended in the pediatric population. Many …

Background Cell-culture–derived influenza vaccines may enable a closer antigenic match to
circulating strains of influenza virus by avoiding egg-adapted mutations. Methods We …

OBJECTIVE Young children are at increased risk for influenza-related complications. Safety
and immunogenicity of a cell-based quadrivalent inactivated influenza vaccine (QIVc) was …

Influenza is common in healthy children and adolescents and is associated with a high rate
of hospitalization in this group, especially for those< 5 years. Although the WHO has …

Influenza viruses have affected the world for over a century, causing multiple pandemics.
Throughout the years, many prophylactic vaccines have been developed for influenza; …

Prior vaccination can alternately enhance or attenuate influenza vaccine immunogenicity
and effectiveness. Analogously, we found that vaccine immunogenicity was enhanced by …

Background Children are an important target group for influenza vaccination, but few studies
have prospectively evaluated influenza vaccine efficacy (VE) in children under 3 years of …

Introduction This paper summarizes the safety and immunogenicity data of Influvac Tetra
across all age groups starting from 6 months of age, obtained during its clinical development …

Influenza is a major cause of highly contagious respiratory illness resulting in high mortality
and morbidity worldwide. Annual vaccination is an effective way to prevent infection and …